Table 2 Demographic and clinical characteristics in 38 Italian patients with fibromyalgia syndrome treated with medical cannabis
From: Medical cannabis for the treatment of fibromyalgia syndrome: a retrospective, open-label case series
Parameter | N = 38 | |||
|---|---|---|---|---|
Gender, female: male | 36:2 | |||
|  | Mean | ± SD | Median | IQR |
Age, years | 56.6 | 9.8 | 56 | 10.75 |
Months between diagnosis of FMS and prescription of MC | 91.1 | 73.5 | 78 | 84 |
Body mass index (Kg/m2) | 25.8 | 5.8 | 24 | 5.5 |
Numerical Rating Scale | 8.2 | 1.4 | 8 | 1.5 |
Oswestry disability index | 55.5 | 17.6 | 55 | 29.5 |
HADS anxiety | 12 | 4.5 | 11.5 | 8 |
HADS depression | 11.7 | 4.6 | 12.5 | 7.25 |
Widespread Pain Index | 14.4 | 4.1 | 15 | 7 |
SyS | 10.1 | 1.4 | 10.5 | 1.5 |